Friday, October 4, 2013

Report: NFL to investigate Josh Freeman medical leak

Posted October 02, 2013

Josh Freeman was asked to skip today's team meeting.(Jim Rogash/Getty Images)

The NFL reportedly will investigate the leak of Josh Freeman?s medical information. (Jim Rogash/Getty Images)

The NFL plans to investigate the leak of Buccaneers quarterback Josh Freeman?s medical information and a report that he was a participant in the league?s drug program, according to Ian Rapoport of NFL.com.

Rapoport tweeted that fines for violating player confidentiality range from $10,000 to $500,000.

MMQB: One big mess in Tampa Bay

A Monday?report from ESPN?s Chris Mortensen?revealed that Freeman was a Stage 1 participant in the NFL?s drug program. Freeman reportedly has a temporary use exemption for a prescription drug outside the boundaries of the NFL?s substance-abuse policies. A Stage 1 status does not automatically indicate that Freeman ever tested positive for any banned substance without an exemption.

SI VIDEO: Who looks worse, Bucs or Josh Freeman?

On Monday, Freeman issued a response through his agents explaining the report, and his participation in the program as first posted by?Pro Football Talk.

The ongoing drama between Freeman and the Bucs includes a Wednesday report by SI.com?s Jim Trotter that Freeman?has been fined twice by the club in the last month, including once in the last week, for conduct detrimental to the team. Freeman reportedly plans to appeal the infractions that include missing at least one team meeting and participating in an unauthorized media interview.

The fines could give Tampa Bay ammunition to suspend Freeman without pay and allow the team to attempt to trade the fifth-year quarterback while not paying a portion of his salary.

Source: http://tracking.si.com/2013/10/02/josh-freeman-leak-investigation/

Kevin Clash Walmart Black Friday 2012 Paula Broadwell Tilted Kilt Barbara Palvin Nick Foles Auguste Rodin

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.